搜尋結果
Slowing ALS Progression Through Gene Therapy
Forbes· 1 日前This story is part of a series on the current progression in Regenerative Medicine. In 1999, I ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 2 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Prioritizing Accessibility And Inclusion In AI Development
Forbes· 4 日前As the use of artificial intelligence (AI) continues to be more prolific in our society, its ...
Sino-French ties bolster China-EU relations
China Daily· 5 日前Following German Chancellor Olaf Scholz's visit to China in April, President Xi Jinping's state visit to France in May will ...
Utah GOP picks Trump-backed mayor as nominee to replace Sen. Mitt Romney, but primary foes await
Bastillepost· 6 日前An evening normally devoted to presidents, journalists and comedians taking outrageous pokes at ...